Visualitzant tema Sanitari Integral d'Utilització Pública de Catalunya

El Racó Digital: Saber Fer a Internet

Basagaña-Farrés, Miriam; Galvan-Bou, Nerea; Puyal-González, Cristina (2019-11)

RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test

Kramer, Claire; Yaniz-Galende, Elisa; Pellegrino, Benedetta; ter Haar, Natalja; Llop-Guevara, Alba; Herencia Ropero, Andrea; Serra, Violeta (Wiley, 2023-11)

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Compadre, Amanda; van Biljon, Lillian; Valentine, Mark; Graham, Emily; Fashemi, Bisiayo; Herencia Ropero, Andrea; Llop-Guevara, Alba; Serra, Violeta (American Association for Cancer Research, 2023-07-01)

Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review

Delara, Ritchie; Yang, Jie; Suarez Salvador, Elena; Vora, Sujay; Magriña, Javier; Butler, Kristina (Elsevier, 2021-11-19)

Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques

Salicrú, Sabina; Centeno-Mediavilla, Cristina; Franco-Camps, Silvia; Díaz-Feijoo, Berta; Gil-Moreno, Antonio; Carbonell-Socias, Melchor; Colás Ortega, Eva; OAKNIN, ANA; PEREZ BENAVENTE, ASUNCION (2018)

Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey

Huijskens, Sophie C.; Kroon, Petra S.; Gaze, Mark N.; Gandola, Lorenza; Bolle, Stephanie; Supiot, Stephane; Giralt López de Sagredo, Jordi (Elsevier, 2021-03-01)

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Walma, M. S.; Rombouts, S. J.; Brada, L. J. H.; Borel Rinkes, I. H.; Bosscha, K.; Bruijnen, R. C.; Pando Rau, Elizabeth (BMC, 2021-04-29)

Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study

Ramlee, Syafiq; Hulse, David; Bernatowicz, Kinga; Pérez López, Raquel; Sala, Evis; Aloj, Luigi (MDPI, 2022-07-27)

Radiomics and Machine Learning for Skeletal Muscle Injury Recovery Prediction

Eleftheriadis, Vasileios; Herance, Jose Raul; Paneta, Valentina; Paun, Bruno; Aparicio Gómez, Carolina; Venegas, Vanesa; Marotta, Mario; Loudos, George (IEEE, 2023-11)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance

Izquierdo, Cristian; Casas Masnou, Guillem; Martin-Isla, Carlos; Campello, Victor M.; Gkontra, Polyxeni; Guala, Andrea; Rodríguez Palomares, Jose Fernando (Frontiers Media, 2021-10-29)

Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial

Carles Galceran, Joan; Mellado, Begoña; Méndez-Vidal, María J.; Vázquez, Sergio; Gonzalez-del-Alba, Aranzazu; Morales Barrera, Rafael; Alonso-Gordoa, Teresa (Elsevier, 2022-09)

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Heidenreich, Axel; Gillessen, Silke; Heinrich, Daniel; Keizman, Daniel; O'Sullivan, Joe M; Carles Galceran, Joan (BMC, 2019-01-07)

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

Janssen, Harry L A; Hou, Jinlin; Asselah, Tarik; Chan, Henry Lik Yuen; Zoulim, Fabien; Tanaka, Yasuhito; Buti Ferret, Maria (BMJ, 2023-07)

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Besse, Benjamin; Garcia Campelo, Rosario; cobo, manuel; Mascaux, C; Madroszyk, Anne; FELIP, ENRIQUETA (Elsevier, 2023-09-11)

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

Aparicio, Jorge; Virgili Manrique, Anna Cristina; Muñoz Boza, Félix; Galván, Patricia; Richart, Paula; Hernando Cubero, Jorge; Capdevila Castillon, Jaume (Springer, 2022-11)

Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy

Choueiri, T.; Suárez Rodríguez, Cristina; Hainsworth, John; Voog, Eric; Duran, Ignacio; Porta, Camillo (Oxford University Press, 2022-12)

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Van Cutsem, Eric; Tempero, Margaret A.; Sigal, Darren; Fazio, Nicola; Macarulla Mercadé, Teresa; Oh, Do-Youn (American Society of Clinical Oncology, 2020-09-20)

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Wiendl, Heinz; Montalban Gairín, Xavier; Alvarez, Enrique; Davydovskaya, Maria; Delgado, Silvia R; Bar-Or, Amit (SAGE Publications, 2022-05)

Rapid Colorimetric Detection of Wound Infection with a Fluidic Paper Device

Hoyo, Javier; Bassegoda, Arnau; Ferreres Cabanes, Guillem; Hinojosa-Caballero, Dolores; Gutiérrez-Capitán, Manuel; Baldi, Antonio (MDPI, 2022-08-15)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

Vigón, Lorena; Vázquez-Morón, Sonia; Berenguer, Juan; González-García, Juan; Jiménez-Sousa, María Ángeles; Guardiola, Josep M.; GESIDA 3603b Cohort Study Group (Nature Publishing Group, 2019-08-21)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol

El Racó Digital: Saber Fer a Internet

RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review

Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques

Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study

Radiomics and Machine Learning for Skeletal Muscle Injury Recovery Prediction

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance

Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Rapid Colorimetric Detection of Wound Infection with a Fluidic Paper Device

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol

El Racó Digital: Saber Fer a Internet ﻿

RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test ﻿

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer ﻿

Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review ﻿

Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques ﻿

Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey ﻿

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial ﻿

Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study ﻿

Radiomics and Machine Learning for Skeletal Muscle Injury Recovery Prediction ﻿

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance ﻿

Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial ﻿

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program ﻿

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection ﻿

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 ﻿

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01) ﻿

Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy ﻿

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma ﻿

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study ﻿

Rapid Colorimetric Detection of Wound Infection with a Fluidic Paper Device ﻿

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

El Racó Digital: Saber Fer a Internet

RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review

Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques

Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study

Radiomics and Machine Learning for Skeletal Muscle Injury Recovery Prediction

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance

Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Rapid Colorimetric Detection of Wound Infection with a Fluidic Paper Device

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR